GLUC (Glucose Health) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GLUC Glucose Health Inc GLUC
38 GF Score
Price $0.39
View Full Analysis

What is Glucose Health 3-Year EBITDA Growth Rate?

Glucose Health GLUC 38 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2023. GuruFocus rates GLUC with a GF Score™ of 38/100.

Glucose Health's EBITDA per Share for the three months ended in Sep. 2023 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Glucose Health  (OTCPK:GLUC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Glucose Health 3-Year EBITDA Growth Rate Related Terms

GLUC vs RTON, BDPT, SMFL: 3-Year EBITDA Growth Rate Comparison

For the Packaged Foods subindustry, Glucose Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glucose Health 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Glucose Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Glucose Health's 3-Year EBITDA Growth Rate falls into.


GLUC
38GF Score
Glucose Health Inc GLUC
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glucose Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Glucose Health (GLUC) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2023. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Glucose Health and its competitors.
Is Glucose Health's 3-Year EBITDA Growth Rate too high?
Glucose Health's current 3-Year EBITDA Growth Rate is 0.00%. Overall, Glucose Health has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Glucose Health's 3-Year EBITDA Growth Rate compare to RTON and BDPT?
Glucose Health's 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Consumer Packaged Goods industry. The industry median 3-Year EBITDA Growth Rate is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.00, based on 1,677 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Glucose Health and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glucose Health's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glucose Health stock overvalued right now?
Glucose Health (GLUC) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Glucose Health's overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Glucose Health (GLUC), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Glucose Health Business Description

Address 609 SW 8th Street, Suite 600, 6th Floor, Bentonville, AR, USA, 72712
Glucose Health Inc is an own-label distributor of nutritional beverages. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber-infused nutritional beverages. The Company has identified two underserved consumer markets and has launched two brands to serve these markets, which are GlucoDown and FIBER UP. The Company currently has one single operating and reporting segment, which is the manufacturing and distribution of nutritional beverages. It generates all of its revenue from sales of nutritional beverages. The beverages are sold through the Company's website as well as through retailers.
38GF Score

Get the complete analysis for GLUC

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price